SLC27A5 and metabolic dysfunction-associated steatohepatitis: Expression of SLC27A5 is up-regulated in fat-laden hepatocytes and down-regulated during the progression from NASH to cirrhosis, likely due to fat loss occurring during the late stage of the disease.